Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10761-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10761-1-AP, RRID:AB_2183280
- Product name
- Secretogranin V antibody
- Antibody type
- Polyclonal
- Description
- Secretogranin V antibody (Cat. #10761-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, rat, mouse and has been validated for the following applications: IF, IHC, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references The role of LRRC15-SCG5 in ECM protein binding as a prognostic signature for urothelial carcinoma.
The potential of secretogranin V as a prognostic biomarker in non-small cell lung cancer.
Transcriptomic heterogeneity of non-beta islet cells is associated with type 2 diabetes development in mouse models.
Expression profile and function of secretogranin V, and its effects on the malignant behavior of esophageal squamous cell carcinoma.
Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin.
Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma.
Dong SW, Chen CH, Tzou KY, Hu SW, Wu CC, Li CH
American journal of cancer research 2025;15(5):2301-2318
American journal of cancer research 2025;15(5):2301-2318
The potential of secretogranin V as a prognostic biomarker in non-small cell lung cancer.
Zhang W, Wang R, Guo R, Wang Y, Wang H, Li Y, Li X, Song J
Scientific reports 2025 May 13;15(1):16589
Scientific reports 2025 May 13;15(1):16589
Transcriptomic heterogeneity of non-beta islet cells is associated with type 2 diabetes development in mouse models.
Gottmann P, Speckmann T, Stadion M, Chawla P, Saurenbach J, Ninov N, Lickert H, Schürmann A
Diabetologia 2025 Jan;68(1):166-185
Diabetologia 2025 Jan;68(1):166-185
Expression profile and function of secretogranin V, and its effects on the malignant behavior of esophageal squamous cell carcinoma.
Hamrah MH, Kanda M, Sato Y, Zhu H, Bayasgalan T, Garza F, Shinozuka T, Ito Y, Sasahara M, Shimizu D, Umeda S, Takami H, Hattori N, Hayashi M, Tanaka C, Kodera Y
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 2024 Nov 28;37(12)
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 2024 Nov 28;37(12)
Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin.
Xin Y, Jiang Q, Liu C, Qiu J
Aging 2023 Nov 3;15(21):12225-12250
Aging 2023 Nov 3;15(21):12225-12250
Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma.
Sakaguchi T, Yoshino H, Sugita S, Miyamoto K, Yonemori M, Osako Y, Meguro-Horike M, Horike SI, Nakagawa M, Enokida H
Oncotarget 2018 May 1;9(33):23003-23017
Oncotarget 2018 May 1;9(33):23003-23017
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse brain tissue were subjected to SDS PAGE followed by western blot with 10761-1-AP(SCG5 antibody) at dilution of 1:2000
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The Secretogranin V antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human Secretogranin V. This antibody recognizes human,mouse,rat antigen. The Secretogranin V antibody has been validated for the following applications: ELISA, WB, IHC analysis.
